Immunological efficacy and tolerability of vaccination in patients with noncommunicable diseases

QR Code

Immunological efficacy and tolerability of vaccination in patients with noncommunicable diseases

Aim. To study the efficacy and tolerability of Sputnik V vaccination in patients with noncommunicable diseases (NCDs) compared with healthy individuals.Material and methods. The retrospective analysis included data from 800 men and women aged 18 to 90 who were vaccinated from February to May 2021 at...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. M. Drapkina, M. N. Mamedov, V. A. Kutsenko, L. N. Ryzhakova, A. V. Emelyanov, B. U. Mardanov, A. V. Kontsevaya
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2022-04-01
Series:	Российский кардиологический журнал
Subjects:	vaccination sputnik v noncommunicable diseases
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4890
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Trends of vaccination against COVID-19 among pregnant women in Siberia
by: N. V. Artymuk, et al.
Published: (2022-03-01)

COVID-19 Vaccination Issues in Solid Organ Transplant Recipients
by: E. V. Parabina, et al.
Published: (2021-08-01)

Comparative analysis of a survey of outand inpatient physicians on secondary prevention of noncommunicable diseases
by: M. N. Mamedov, et al.
Published: (2025-07-01)

Dynamics of humoral immunity during natural SARS-CoV-2 infection and/or after vaccination with the ‘Sputnik V’ vaccine
by: A. V. Ivanov, et al.
Published: (2024-11-01)

Evaluation of the Effectiveness of Vaccination of Russian Railways employees
by: N. A. Kostenko, et al.
Published: (2022-11-01)

Gender characteristics of the prevalence of noncommunicable diseases in the adult population of the Vladimir region
by: M. N. Mamedov, et al.
Published: (2023-12-01)

Stress in individuals with noncommunicable diseases: ESSE-RF and ESSE-RF2 data
by: L. I. Gomanova, et al.
Published: (2024-11-01)

Potential and limitations of secondary prevention of noncommunicable diseases: data from a survey of Russian outpatient physicians
by: M. N. Mamedov, et al.
Published: (2024-09-01)

Incidence of COVID-19 among Vaccinated with Sputnik V and CoviVac Vaccines (Results of the Telephone Survey for the Epidemic Season 2021–2022 in St. Petersburg)
by: M. K. Erofeeva, et al.
Published: (2024-01-01)

Thrombosis in unvaccinated and Gam-COVID-Vac-vaccinated patients with COVID-19
by: A. G. Moiseeva, et al.
Published: (2022-08-01)

Safety of Gam-COVID-Vac (Sputnik V) Combined Vector Vaccine in Patients With Immunoinflammatory Rheumatic Diseases: Preliminary Data
by: A. N. KULIKOV, et al.
Published: (2022-11-01)

The use of the combined vector vaccine GamCOVID-Vac (Sputnik V) in patients with immuno-inflammatory rheumatic diseases: safety issues-news
by: A. N. Kulikov, et al.
Published: (2023-06-01)

Evaluation of secondary prevention of noncommunicable diseases at the outpatient healthcare level in the Commonwealth of Independent States countries
by: M. N. Mamedov, et al.
Published: (2024-11-01)

Assessment of the clinical status and behavioral risk factors in patients with cardiovascular and other noncommunicable diseases in Russia and neighboring countries during quarantine and self-isolation
by: O. M. Drapkina, et al.
Published: (2022-04-01)

Helminths and intestinal microbiota interaction: role in the development of noncommunicable diseases
by: T. S. Sokolova, et al.
Published: (2019-10-01)

Frequency of risk factors for chronic noncommunicable diseases among physicians in Russian Federation on the model of Tomsk Region
by: O. S. Kobyakova, et al.
Published: (2018-12-01)

Behavioral risk factors and clinical course of cardiovascular diseases and other noncommunicable diseases during quarantine in various regions of Russia
by: M. N. Mamedov, et al.
Published: (2021-10-01)

Study of Humoral Immunity against Coronavirus Infection COVID-19 in Vaccinated Individuals with Vaccines Available in the Republic of Belarus (Sputnik V (Gam-COVID-Vac), RF and Sinopharm (BBIBP-CorV), PRC)
by: K. S. Korsak, et al.
Published: (2023-03-01)

The prevalence of risk factors for chronic noncommunicable diseases among medical specialists in the Tomsk region
by: O. S. Kobyakova, et al.
Published: (2020-03-01)

Impact of optimal therapy for noncommunicable diseases on the course and outcome of COVID-19 inpatients
by: I. A. Frolova, et al.
Published: (2022-04-01)

Preventive counseling of patients with risk factors for noncommunicable diseases in clinical practice. Analytical review
by: O. M. Drapkina, et al.
Published: (2025-02-01)

Immunogenicity evaluation of Gam-COVID-Vac (Sputnik V)
by: I. A. Kirillov, et al.
Published: (2022-12-01)

Mobile applications for anxiety and stress reduction: potential for preventing noncommunicable diseases
by: K. A. Zamyatin, et al.
Published: (2021-10-01)

Gender and age-speciﬁc eating behaviour in urban populations at risk of chronic noncommunicable diseases: an observational cohort study
by: V. V. Gorban, et al.
Published: (2022-02-01)

The scope of a comprehensive primary healthcare approach in addressing the rising burden of noncommunicable diseases
by: Senthilkumar Ramasamy, et al.
Published: (2025-04-01)

Noncommunicable Diseases and Global Health Security: Scaling up Action in Humanitarian Crises for Sustainable Recovery
by: Téa E. Collins, et al.
Published: (2025-06-01)

Proceedings of the second Africa regional meeting of the world noncommunicable disease federation
by: Davison Munodawafa, et al.
Published: (2025-04-01)

Adenovirus-Based Single-Dose Vaccines for SARS-CoV-2: A Review
by: Vivek P Chavda, et al.
Published: (2025-07-01)

Study of adherence of pharmaceutical workers and population to immunoprophylaxis of coronaviral infection
by: I. Yu. Nefedov, et al.
Published: (2021-08-01)

Prevention of noncommunicable diseases as an opportunity to increase life expectancy and healthy longevity
by: G. Ya. Maslennikova, et al.
Published: (2019-04-01)

Immunological efficacy of hepatitis B vaccine
by: E. V. Eesaulenko, et al.
Published: (2025-06-01)

Challenges in Managing Noncommunicable Diseases: Perspectives of Family Physicians Practicing in Public‒Private Partnerships: A Qualitative Study
by: Aboalfazl Marvi, et al.
Published: (2025-06-01)

Midline evaluation training outcomes for primary care nurses on noncommunicable diseases in Hwange district
by: Davison Munodawafa, et al.
Published: (2025-04-01)

Evaluating the family adoption program as a noncommunicable disease surveillance tool in India: A systematic review
by: Urvish Joshi, et al.
Published: (2025-07-01)

Sixteen-year incidence changes of four main disease classes in the North Caucasus
by: M. N. Mamedov, et al.
Published: (2024-05-01)

COVID-19 from the interdisciplinary standpoint. Round table
by: M. N. Mamedov, et al.
Published: (2021-05-01)

Experience in implementing workplace wellbeing programs in Russia: results of a survey of employers on the ATRIA platform
by: A. A. Antsiferova, et al.
Published: (2022-07-01)

Regional Characteristics of Hospital Admissions and Outpatients Visits with Arterial Hypertension from the Point of the WHO Concept of Ambulatory Care Sensitive Conditions
by: A. V. Kontsevaya, et al.
Published: (2020-12-01)

Antibody Kinetics of Immunological Memory in SARS-CoV-2-Vaccinated Healthcare Workers—The ORCHESTRA Project
by: Seyedalireza Seyedi, et al.
Published: (2025-06-01)

Monitoring of noncommunicable diseases risk factors in national adult health surveys: a review of international experience
by: E. O Korotkova, et al.
Published: (2022-03-01)